title: Transarterial chemoembolization using iodized oil for unresectable hepatocellular carcinoma: perspective from multistep hepatocarcinogenesis.
abstract: Transarterial chemoembolization (TACE) using iodized oil (Lipiodol(®)) (Lp-TACE) as a carrier of chemotherapeutic agents has been routinely performed to control hepatocellular carcinomas (HCC) in Japan, and its use has yielded fairly beneficial therapeutic results. Lipiodol is thought to pass through the tumor sinusoids of HCC and reach the outflow drainage areas, namely, the portal venous side of the tumor. By doing this, Lipiodol blocks not only the tumor's arterial inflow but also its portal venous outflow, providing sufficient ischemic effects. It is known that the inflow blood system, tumor sinusoids, and outflow blood system change drastically during the process of multistep hepatocarcinogenesis; thus, it is reasonable to postulate that the distribution of Lipiodol and the subsequent therapeutic effect of Lp-TACE may also change during that process. Arterial inflow to HCC is highest for moderately differentiated HCC (mHCC) and is relatively low in well or poorly differentiated HCC (wHCC and pHCC, respectively). It has been suggested that the metabolic state of wHCC and mHCC is aerobic, while that of pHCC is anaerobic. The tumor sinusoids in wHCC and mHCC are small in size and large in number, while those in pHCC are large in size and small in number. This finding results in a greater chance of tumor cell exposure to chemotherapeutic agents in the former and a lesser chance in the latter. The outflow tract, namely, the drainage system via the residual portal venous branches within the pseudocapsule, is more complete in mHCC and pHCC and less so in wHCC. Considering all of these components of HCC of different histological grades, Lp-TACE should have the greatest effect on mHCC and a relatively low effect on wHCC and pHCC. To achieve consistently high therapeutic results, it is important to consider these components, which affect the sensitivity of HCC to Lp-TACE, to maximize both the chemotherapeutic and ischemic effects of this therapy.
authors.affiliation: Department of Radiology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
authors.forename: Kengo
authors.initials: K
authors.lastname: Yoshimitsu
keywords: embolotherapy Lipiodol; histological grade; liver cancer; multistep carcinogenesis
references.citation: J Vasc Interv Radiol. 2013 Apr;24(4):490-500
references.pmid: 23466316
references.citation: J Comput Assist Tomogr. 2007 Mar-Apr;31(2):188-92
references.pmid: 17414751
references.citation: Eur J Radiol. 2012 Jun;81(6):1116-21
references.pmid: 21420813
references.citation: J Hepatobiliary Pancreat Sci. 2010 Jul;17(4):407-9
references.pmid: 19885639
references.citation: AJR Am J Roentgenol. 2002 Apr;178(4):885-97
references.pmid: 11906868
references.citation: Cardiovasc Intervent Radiol. 2012 Feb;35(1):82-9
references.pmid: 21203761
references.citation: Hum Pathol. 1992 Jun;23(6):619-26
references.pmid: 1317345
references.citation: Abdom Imaging. 2011 Jun;36(3):264-72
references.pmid: 21267562
references.citation: Cardiovasc Intervent Radiol. 2001 Nov-Dec;24(6):383-7
references.pmid: 11907744
references.citation: Hepatol Res. 2014 Feb;44(2):201-8
references.pmid: 23551984
references.citation: Radiology. 2009 Aug;252(2):605-14
references.pmid: 19703890
references.citation: AJR Am J Roentgenol. 2008 Jan;190(1):W28-34
references.pmid: 18094269
references.citation: Hepatogastroenterology. 2002 Jan-Feb;49(43):72-8
references.pmid: 11941988
references.citation: Cardiovasc Intervent Radiol. 2013 Aug;36(4):1023-9
references.pmid: 23238851
references.citation: Radiology. 1991 Feb;178(2):493-7
references.pmid: 1846240
references.citation: J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 1):183-90
references.pmid: 16706831
references.citation: Radiology. 1998 Jan;206(1):161-6
references.pmid: 9423667
references.citation: AJR Am J Roentgenol. 1999 Apr;172(4):969-76
references.pmid: 10587130
references.citation: J Vasc Interv Radiol. 2007 Mar;18(3):365-76
references.pmid: 17377182